Given the findings of this study, it is reasonable to conclude that the CB2-R63 variant, which is associated with reduced immunomodulatory function and autoimmune diseases, is predominantly linked to autoimmune conditions like RA. This evidence concerns the gene CNR2 and rheumatoid arthritis.